NCT01631071 Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains Status COMPLETED Phase NA
NCT01626820 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults Status COMPLETED Phase PHASE3
NCT01625689 Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine Status COMPLETED Phase PHASE2
NCT01623518 A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1 Status COMPLETED Phase PHASE1
NCT01617239 Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine Status COMPLETED Phase PHASE1
NCT01612000 Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults Status COMPLETED Phase PHASE1/PHASE2
NCT01610245 Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza Status COMPLETED Phase PHASE3
NCT01609998 Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents Status COMPLETED Phase PHASE1
NCT01607112 A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above Status COMPLETED Phase PHASE3
NCT01599390 Influenza Burden Assessment in the United States, July1997 - up to April 2009 Status COMPLETED Phase N/A
NCT01592799 Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain Status COMPLETED Phase NA
NCT01584908 Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients Status COMPLETED Phase N/A
NCT01582633 Assessment of Needle-free Disposable-syringe Jet Injector (DSJI) ID Dose-sparing of Pandemic A H1N1 Influenza Vaccine Status UNKNOWN Phase PHASE2/PHASE3
NCT01580033 Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine Status COMPLETED Phase PHASE3
NCT01579916 A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults Status COMPLETED Phase PHASE4
NCT01578317 Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant Status COMPLETED Phase PHASE1/PHASE2
NCT01573312 H5N1 Vaccination With and Without AS03: Systems Biology Analysis Status COMPLETED Phase PHASE1
NCT01561768 A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults Status COMPLETED Phase PHASE2
NCT01560793 Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years Status COMPLETED Phase PHASE1